SRAGE, inflammation, and risk of atrial fibrillation: Results from the Atherosclerosis Risk in Communities (ARIC) Study

Journal of Diabetes and its Complications

Volumn 29, Issue 2, 2015, Pages 180-185

  Al Rifai, Mahmoud ^a   Schneider, Andrea L C ^a,b   Alonso, Alvaro ^c   Maruthur, Nisa ^a,b   Parrinello, Christina M ^a   Astor, Brad C ^d   Hoogeveen, Ron C ^e   Soliman, Elsayed Z ^f   Chen, Lin Y ^g   Ballantyne, Christie M ^e   Halushka, Marc K ^b   Selvin, Elizabeth ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Advanced glycation end products; Atrial fibrillation; C reactive protein; Epidemiology; Inflammation

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; AUTACOID; BIOLOGICAL MARKER; GAMMA-GLUTAMYLTRANSFERASE, HUMAN; IMMUNOGLOBULIN RECEPTOR;

ADULT; ARTICLE; ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY; CARDIOVASCULAR RISK; CLINICAL STUDY; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BIOLOGICAL MODEL; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; IMMUNOLOGY; INCIDENCE; RISK FACTOR; SOLUBILITY; UNITED STATES;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BIOMARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INCIDENCE; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; SOLUBILITY; UNITED STATES;

EID: 84923094008     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2014.11.008     Document Type: Article

References (42)

1. M. Acevedo, R. Corbalan, S. Braun, J. Pereira, C. Navarrete, and I. Gonzalez C-reactive protein and atrial fibrillation: "Evidence for the presence of inflammation in the perpetuation of the arrhythmia." International Journal of Cardiology 108 2006 326 331
2. A.O. Akinkuolie, J.E. Buring, P.M. Ridker, and S. Mora A novel protein glycan biomarker and future cardiovascular disease events Journal of the American Heart Association 3 2014 e001221
3. A. Alonso, S.K. Agarwal, and E.Z. Soliman Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study American Heart Journal 158 2009 111 117
4. A. Alonso, W. Tang, S.K. Agarwal, E.Z. Soliman, A.M. Chamberlain, and A.R. Folsom Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: The ARIC study International Journal of Cardiology 155 2012 217 222
5. G. Basta, A.M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes Cardiovascular Research 63 2004 582 592
6. G. Basta, A.M. Sironi, and G. Lazzerini Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein The Journal of Clinical Endocrinology and Metabolism 91 2006 4628 4634
7. S. Bo, R. Gambino, and M. Durazzo Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: A possible implication for oxidative stress World Journal of Gastroenterology 11 2005 7109 7117
8. J.K. Bower, J.S. Pankow, and M. Lazo Three-year variability in plasma concentrations of the soluble receptor for advanced glycation end products (sRAGE) Clinical Biochemistry 47 2014 132 134
9. S.R. Brickey, J.R. Ryder, D.R. McClellan, and G.Q. Shaibi Soluble receptor for advanced glycation end products independently predicts cardiometabolic syndrome in Latino youth Pediatric Diabetes 2013 10.1111/pedi.12095
10. K.M. Choi, K.A. Han, and H.J. Ahn Effects of exercise on sRAGE levels and cardiometabolic risk factors in patients with type 2 diabetes: A randomized controlled trial The Journal of Clinical Endocrinology and Metabolism 97 2012 3751 3758
11. L.C. De Vos, D.J. Mulder, and A.J. Smit Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease Arteriosclerosis, Thrombosis, and Vascular Biology 34 2014 933 938
12. S. Dublin, N.L. Glazer, and N.L. Smith Diabetes mellitus, glycemic control, and risk of atrial fibrillation Journal of General Internal Medicine 25 2010 853 858
13. C. Falcone, E. Emanuele, and A. D'Angelo Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men Arteriosclerosis, Thrombosis, and Vascular Biology 25 2005 1032 1037
14. J.M. Forbes, S.R. Thorpe, and V. Thallas-Bonke Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy Journal of the American Society of Nephrology 16 2005 2363 2372
15. T.T. Issac, H. Dokainish, and N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation: A systematic review of the published data Journal of the American College of Cardiology 50 2007 2021 2028
16. S. Kaptoge, E. Di Angelantonio, and L. Pennells C-reactive protein, fibrinogen, and cardiovascular disease prediction The New England Journal of Medicine 367 2012 1310 1320
17. I. Kriszbacher, M. Koppán, and J. Bódis Inflammation, atherosclerosis, and coronary artery disease The New England Journal of Medicine 353 2005 429 430 (author reply 429-30)
18. P. Libby Inflammation and cardiovascular disease mechanisms The American Journal of Clinical Nutrition 83 2006 456S 460S
19. P. Libby Inflammation in atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 32 2012 2045 2051
20. S. Ligthart, S. Sedaghat, M.A. Ikram, A. Hofman, O.H. Franco, and A. Dehghan EN-RAGE: A novel inflammatory marker for incident coronary heart disease Arteriosclerosis, Thrombosis, and Vascular Biology 34 2014 2695 2699 (published, online Oct 23)
21. H. Maillard-Lefebvre, E. Boulanger, M. Daroux, C. Gaxatte, B.I. Hudson, and M. Lambert Soluble receptor for advanced glycation end products: A new biomarker in diagnosis and prognosis of chronic inflammatory diseases Rheumatology 48 2009 1190 1196
22. J.E. Mason, R.D. Starke, and J.E. Van Kirk Gamma-glutamyl transferase: A novel cardiovascular risk biomarker Preventive Cardiology 13 2010 36 41
23. H. Momma, K. Niu, and Y. Kobayashi Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: A cross-sectional study Diabetology and Metabolic Syndrome 6 2014 33
24. V.M. Monnier, G.T. Mustata, and K.L. Biemel Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: An update on "a puzzle nearing resolution" Annals of the New York Academy of Sciences 1043 2005 533 544
25. V.M. Monnier, D.R. Sell, and S. Genuth Glycation products as markers and predictors of the progression of diabetic complications Annals of the New York Academy of Sciences 1043 2005 567 581
26. V. Palmieri, A. Celentano, and M.J. Roman Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: The Strong Heart Study American Heart Journal 145 2003 467 474
27. N. Papageorgiou, D. Tousoulis, G. Siasos, and C. Stefanadis Is fibrinogen a marker of inflammation in coronary artery disease? Hellenic Journal of Cardiology 51 2010 1 9
28. S. Petta, F.S. Macaluso, and M.R. Barcellona Serum gamma-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases PLoS One 7 2012 e51165
29. K. Prasad Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: Myth or reality International Journal of Angiology 23 2014 11 16
30. S. Raposeiras-Roubin, B.K. Rodino-Janeiro, and L. Grigorian-Shamagian Evidence for a role of advanced glycation end products in atrial fibrillation International Journal of Cardiology 157 2012 397 402
31. C.M. Rebholz, B.C. Astor, and M.E. Grams Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: The Atherosclerosis Risk in Communities study Nephrology, Dialysis, Transplantation 2014 10.1093/ndt/gfu282 (published online Aug 21)
32. S. Santos, T.W. Rooke, K.R. Bailey, J.P. McConnell, and I.J. Kullo Relation of markers of inflammation (C-reactive protein, white blood cell count, and lipoprotein-associated phospholipase A2) to the ankle-brachial index Vascular Medicine 9 2004 171 176
33. A.L. Schneider, M. Lazo, and C.E. Ndumele Liver enzymes, race, gender and diabetes risk: The Atherosclerosis Risk in Communities (ARIC) Study Diabetic Medicine 30 2013 926 933
34. S.R. Selejan, J. Poss, L. Hewera, A. Kazakov, M. Bohm, and A. Link Role of receptor for advanced glycation end products in cardiogenic shock Critical Care Medicine 40 2012 1513 1522
35. E. Selvin, M.K. Halushka, and A.M. Rawlings sRAGE and risk of diabetes, cardiovascular disease, and death Diabetes 62 2013 2116 2121
36. K.C. Tan, W.S. Chow, and A.W. Tso Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes Diabetologia 50 2007 1819 1825
37. E. Tank, L. Wegman-Points, and K. Siefers Lower soluble RAGE and higher aortic stiffness in African American adolescents: Possible protective effect of higher sRAGE in white youth (867.10) The FASEB Journal 28 2014 867.10
38. N. Vazzana, F. Santilli, C. Cuccurullo, and G. Davi Soluble forms of RAGE in internal medicine Internal and Emergency Medicine 4 2009 389 401
39. H. Vlassara, and G. Striker Glycotoxins in the diet promote diabetes and diabetic complications Current Diabetes Reports 7 2007 235 241
40. S.P. Whelton, P. Roy, and B.C. Astor Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study American Journal of Epidemiology 178 2013 1076 1084
41. X. Yan, Y. Shen, L. Lu, M. Sano, K. Fukuda, and W. Shen Decreased endogenous secretory RAGE and increased hsCRP levels in serum are associated with atrial fibrillation in patients undergoing coronary angiography International Journal of Cardiology 166 2013 242 245
42. D. Zhao, Y. Wang, and Y. Xu Decreased serum endogenous secretory receptor for advanced glycation endproducts and increased cleaved receptor for advanced glycation endproducts levels in patients with atrial fibrillation International Journal of Cardiology 158 2012 471 472